Lip Clinical Trials in Beijing, Beijing Municipality
24 recruitingBeijing, Beijing Municipality, China
Showing 1–20 of 24 trials
Recruiting
Phase 2
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD.204 enrolled43 locationsNCT07327840
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery
Laparoscopic SurgeryLiposomal BupivacaineLocal Infiltration
Beijing Tiantan Hospital190 enrolled1 locationNCT07458256
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology
Laparoscopic SurgeryLiposomal BupivacaineTransversus Abdominis Plane Block+1 more
Beijing Tiantan Hospital110 enrolled1 locationNCT07458295
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery
Laparoscopic SurgeryLiposomal BupivacaineTransversus Abdominis Plane Block
Beijing Tiantan Hospital318 enrolled1 locationNCT07458282
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
Pain ManagementVideo-assisted Thoracoscopic Surgery (VATS)Liposomal Bupivacaine+1 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07432711
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
Pain ManagementVideo-assisted Thoracoscopic Surgery (VATS)Liposomal Bupivacaine+1 more
Beijing Tiantan Hospital134 enrolled1 locationNCT07441902
Recruiting
Not Applicable
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery
Pain ManagementLocal InfiltrationHemorrhoid Surgery+1 more
Beijing Tiantan Hospital156 enrolled1 locationNCT07442539
Recruiting
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Neutral Lipid Storage Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan120 enrolled15 locationsNCT02918032
Recruiting
Phase 1Phase 2
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Hyperlipoproteinemia (a)
Sirius Therapeutics Co., Ltd.84 enrolled1 locationNCT07172646
Recruiting
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
Diabetes MellitusHypertensionDyslipidemias
Beijing Tongren Hospital300 enrolled1 locationNCT05644548
Recruiting
Not Applicable
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
Coronary Artery DiseaseDrug-eluting StentDual Antiplatelet Therapy+1 more
China National Center for Cardiovascular Diseases3,300 enrolled1 locationNCT06014060
Recruiting
Phase 1
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd.12 enrolled1 locationNCT06978647
Recruiting
Phase 2
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren SyndromeInflammatory Myopathy+6 more
Peking University People's Hospital50 enrolled1 locationNCT06794008
Recruiting
Phase 3
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Primary hypercholesterolemiaMetabolic DiseaseDyslipidemias+4 more
Hasten Biopharmaceutical Co., Ltd.210 enrolled18 locationsNCT06568471
Recruiting
Not Applicable
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia
Hyperlipidemias
Peking Union Medical College Hospital120 enrolled1 locationNCT05015348
Recruiting
Phase 2
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Advanced CancerPancreatic AdenocarcinomaCapecitabine+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06405490
Recruiting
Phase 3
Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd.582 enrolled1 locationNCT05621070
Recruiting
Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
Anti Phospholipid Syndrome
Peking Union Medical College Hospital2,000 enrolled18 locationsNCT05230017
Recruiting
Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics
Coronary Heart DiseaseChronic Kidney DiseasesLipid Metabolism Disorders
China-Japan Friendship Hospital470 enrolled1 locationNCT06383208
Recruiting
Integrated Diagnosis and Treatment of CKD on Outcomes
HypertensionChronic Kidney DiseasesHyperlipidemias+4 more
Capital Medical University1,000 enrolled1 locationNCT05242055